% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{LeClerc:902563,
author = {Le Clerc, Sigrid and Lombardi, Laura and Baune, Bernhard T.
and Amare, Azmeraw T. and Schubert, Klaus Oliver and Hou,
Liping and Clark, Scott R. and Papiol, Sergi and Cearns,
Micah and Heilbronner, Urs and Degenhardt, Franziska and
Tekola-Ayele, Fasil and Hsu, Yi-Hsiang and Shekhtman,
Tatyana and Adli, Mazda and Akula, Nirmala and Akiyama,
Kazufumi and Ardau, Raffaella and Arias, Bárbara and Aubry,
Jean-Michel and Backlund, Lena and Bhattacharjee, Abesh
Kumar and Bellivier, Frank and Benabarre, Antonio and
Bengesser, Susanne and Biernacka, Joanna M. and Birner,
Armin and Brichant-Petitjean, Clara and Cervantes, Pablo and
Chen, Hsi-Chung and Chillotti, Caterina and Cichon, Sven and
Cruceanu, Cristiana and Czerski, Piotr M. and Dalkner, Nina
and Dayer, Alexandre and Del Zompo, Maria and DePaulo, J.
Raymond and Étain, Bruno and Jamain, Stephane and Falkai,
Peter and Forstner, Andreas J. and Frisen, Louise and Frye,
Mark A. and Fullerton, Janice M. and Gard, Sébastien and
Garnham, Julie S. and Goes, Fernando S. and
Grigoroiu-Serbanescu, Maria and Grof, Paul and Hashimoto,
Ryota and Hauser, Joanna and Herms, Stefan and Hoffmann, Per
and Jiménez, Esther and Kahn, Jean-Pierre and Kassem, Layla
and Kuo, Po-Hsiu and Kato, Tadafumi and Kelsoe, John R. and
Kittel-Schneider, Sarah and Ferensztajn-Rochowiak, Ewa and
König, Barbara and Kusumi, Ichiro and Laje, Gonzalo and
Landén, Mikael and Lavebratt, Catharina and Leckband, Susan
G. and Tortorella, Alfonso and Manchia, Mirko and
Martinsson, Lina and McCarthy, Michael J. and McElroy, Susan
L. and Colom, Francesc and Millischer, Vincent and Mitjans,
Marina and Mondimore, Francis M. and Monteleone, Palmiero
and Nievergelt, Caroline M. and Nöthen, Markus M. and
Novák, Tomas and O’Donovan, Claire and Ozaki, Norio and
Ösby, Urban and Pfennig, Andrea and Potash, James B. and
Reif, Andreas and Reininghaus, Eva and Rouleau, Guy A. and
Rybakowski, Janusz K. and Schalling, Martin and Schofield,
Peter R. and Schweizer, Barbara W. and Severino, Giovanni
and Shilling, Paul D. and Shimoda, Katzutaka and Simhandl,
Christian and Slaney, Claire M. and Pisanu, Claudia and
Squassina, Alessio and Stamm, Thomas and Stopkova, Pavla and
Maj, Mario and Turecki, Gustavo and Vieta, Eduard and Veeh,
Julia and Witt, Stephanie H. and Wright, Adam and Zandi,
Peter P. and Mitchell, Philip B. and Bauer, Michael and
Alda, Martin and Rietschel, Marcella and McMahon, Francis J.
and Schulze, Thomas G. and Spadoni, Jean-Louis and
Boukouaci, Wahid and Richard, Jean-Romain and Le Corvoisier,
Philippe and Barrau, Caroline and Zagury, Jean-François and
Leboyer, Marion and Tamouza, Ryad},
title = {{HLA}-{DRB}1 and {HLA}-{DQB}1 genetic diversity modulates
response to lithium in bipolar affective disorders},
journal = {Scientific reports},
volume = {11},
number = {1},
issn = {2045-2322},
address = {[London]},
publisher = {Macmillan Publishers Limited, part of Springer Nature},
reportid = {FZJ-2021-04362},
pages = {17823},
year = {2021},
abstract = {Bipolar affective disorder (BD) is a severe psychiatric
illness, for which lithium (Li) is the gold standard for
acute and maintenance therapies. The therapeutic response to
Li in BD is heterogeneous and reliable biomarkers allowing
patients stratification are still needed. A GWAS performed
by the International Consortium on Lithium Genetics
(ConLiGen) has recently identified genetic markers
associated with treatment responses to Li in the human
leukocyte antigens (HLA) region. To better understand the
molecular mechanisms underlying this association, we have
genetically imputed the classical alleles of the HLA region
in the European patients of the ConLiGen cohort. We found
our best signal for amino-acid variants belonging to the
HLA-DRB1*11:01 classical allele, associated with a better
response to Li (p < 1 × 10−3; FDR < 0.09 in
the recessive model). Alanine or Leucine at position 74 of
the HLA-DRB1 heavy chain was associated with a good response
while Arginine or Glutamic acid with a poor response. As
these variants have been implicated in common
inflammatory/autoimmune processes, our findings strongly
suggest that HLA-mediated low inflammatory background may
contribute to the efficient response to Li in BD patients,
while an inflammatory status overriding Li anti-inflammatory
properties would favor a weak response.},
cin = {INM-1},
ddc = {600},
cid = {I:(DE-Juel1)INM-1-20090406},
pnm = {5251 - Multilevel Brain Organization and Variability
(POF4-525)},
pid = {G:(DE-HGF)POF4-5251},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:34497278},
UT = {WOS:000693895300003},
doi = {10.1038/s41598-021-97140-7},
url = {https://juser.fz-juelich.de/record/902563},
}